North by Honeywell Pain Stopper Extra Strength tablets recalled for failed stability
Ultra Seal Corporation is recalling North by Honeywell Pain Stopper Extra Strength tablets nationwide because stability testing found out-of-specification results for Salicylic Acid, an aspirin-related compound.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class III, which typically corresponds to a score of 1 or 2. The source text does not report any illnesses, injuries, or deaths. The hazard is a failed stability specification—a quality/manufacturing issue rather than an acute safety threat—making this a moderate precautionary recall.
Plain-English summary
Ultra Seal Corporation is recalling North by Honeywell Pain Stopper Extra Strength tablets (containing Acetaminophen 250 mg, Aspirin 250 mg, and Caffeine 65 mg) distributed nationwide in the United States. The recall was initiated because stability testing identified out-of-specification results for Salicylic Acid, a compound related to aspirin.
The affected product is Lot #AK-9371 with an expiration date of November 21. The product was packaged in cases of 5,000 packets (2 tablets per packet), for a total of 250,000 tablets, and distributed by Honeywell Safety Products USA in Smithfield, Rhode Island.
Consumers who have purchased this product should stop using it and consult their healthcare provider if they have questions or concerns about their health.
The recalled product
- Product
- North by Honeywell PAIN STOPPER EXTRA STRENGTH (Acetaminophen 250 mg, Aspirin 250 mg, Caffeine 65 mg) tablets, 2 tablets per packet, Packaged in 5,000 Packets/Case, PO# B121242, Item# 853500-01, Dist. By Honeywell Safety Products USA, Smithfield, RI 02917
- Manufacturer
- Ultra Seal Corporation
- Affected units
- 250,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AK-9371
- exp. date 21-Nov
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Terminator decongestant recalled for cGMP deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · failed stability specification
See all →- ModerateCombipatch Transdermal System Recalled for Failed Stability Specifications
FDA (Drugs) · 2021-08-25